Intuitive Surgical, Inc.
NASDAQIntuitive Surgical enters its Q1 results tonight carrying a 6% weekly loss and a wave of freshly cut price targets — yet the analysts who trimmed are, almost to a firm, keeping their buy-equivalent ratings intact. The analyst story this week is one of calibration, not conviction loss. In the 48 hours after the last earnings date on April 21, the bulk of the Street moved quickly…
Snapshot as of 7 May 2026
A new long-form analysis for ISRG this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumIntuitive Surgical enters its Q1 results tonight carrying a 6% weekly loss and a wave of freshly cut price targets — yet the analysts who trimmed are, almost to a firm, keeping their buy-equivalent ratings intact. The…
Intuitive Surgical reports Q1 2026 results on April 30, and the dominant story is a Street that remains broadly constructive even after trimming its ambitions. Analyst activity in the past two weeks has run almost…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ISRG — free to start on ORTEX.
Sign up for free →Open ISRG on ORTEX